PTC THERAPEUTICS, INC. — Director's Dealing 2020

Nov 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2020-11-04

Reporting Person: Jacobson Allan Steven (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-04	Common Stock	M	20000	$10.85	Acquired	23498	Direct
2020-11-04	Common Stock	S	20000	$60.00	Disposed	3498	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-04	Stock Option (Right To Buy)	$10.85	M	20000	Disposed	2023-05-15	Common Stock (20000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right To Buy)	$490.8	2021-04-27	Common Stock (250.0)	250	Direct
Stock Option (Right To Buy)	$218.4	2022-01-10	Common Stock (83.0)	83	Direct
Stock Option (Right To Buy)	$27.05	2024-01-27	Common Stock (10000.0)	10000	Direct
Stock Option (Right To Buy)	$51.0	2025-01-01	Common Stock (12000.0)	12000	Direct
Stock Option (Right To Buy)	$30.86	2026-01-03	Common Stock (12000.0)	12000	Direct
Stock Option (Right To Buy)	$11.23	2027-01-02	Common Stock (12000.0)	12000	Direct
Stock Option (Right To Buy)	$18.01	2028-01-02	Common Stock (14000.0)	14000	Direct
Stock Option (Right To Buy)	$33.02	2029-01-21	Common Stock (14000.0)	14000	Direct
Stock Option (Right To Buy)	$51.16	2030-01-28	Common Stock (10000.0)	10000	Direct

Footnotes

F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2020.

F2: Currently exercisable.

F3: This option was granted on January 29, 2020 and vests over one year in twelve equal monthly installments, commencing on February 29, 2020.